English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [630]
News [1081]
Articles [59]
Editorials [2]
Conferences [101]
elearning [5]
Study shows advanced PET/CT imaging can help improve long-term outcomes for men with recurrent prostate cancer
Study shows advanced PET/CT imaging can help improve long-term outcomes for men with recurrent prostate cancer
Improving nursing support for fertility preservation in women with cancer
Improving nursing support for fertility preservation in women with cancer
Randomized trial finds drug therapy reduces hot flashes during prostate cancer treatment
Randomized trial finds drug therapy reduces hot flashes during prostate cancer treatment
What is the ideal duration of hormone therapy for the treatment of prostate cancer?
What is the ideal duration of hormone therapy for the treatment of prostate cancer?
Hot flush treatment has anti-breast cancer activity, study finds
Hot flush treatment has anti-breast cancer activity, study finds
Genomic test helps flag early aggressive prostate cancer in African American patients
Genomic test helps flag early aggressive prostate cancer in African American patients
SABCS 2025: Study solves a long-standing gap in metastatic breast cancer research and care: accurately measuring treatment response in patients with bone metastases
SABCS 2025: Study solves a long-standing gap in metastatic breast cancer research and care: accurately measuring...
Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations
Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations
SABCS 2025: Sacituzumab govitecan-hziy led to similar progression-free survival as standard of care for certain endocrine therapy-refractory advanced breast cancers
SABCS 2025: Sacituzumab govitecan-hziy led to similar progression-free survival as standard of care for certain...
Pathway discovered to make the most common breast cancer tumour responsive to immunotherapy
Pathway discovered to make the most common breast cancer tumour responsive to immunotherapy
<12345…109>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2026 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top